Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation.

Aguilera, Isabel

Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation. [electronic resource] - Clinical transplantation - 207-12 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1399-0012

10.1111/j.1399-0012.2010.01221.x doi


Adolescent
Adult
Aged
Antibodies, Anti-Idiotypic--adverse effects
Calcineurin--adverse effects
Female
Glutathione Transferase--immunology
Hepatitis, Autoimmune--etiology
Humans
Immunosuppressive Agents--adverse effects
Liver Transplantation--adverse effects
Male
Middle Aged
Survival Rate
Young Adult